mRNA-1283

Phase 3

Moderna, Inc. (MRNA)

Fast TrackLearn about designations

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

22 competitors in COVID-19

Drug Information

Target Indication

COVID-19

Mechanism of Action

mRNA Vaccine

Clinical Trial

NCT05249829

Last updated: 12/3/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Source: FDA Orange Book

Drug Science

Mechanism of action & safety profile

Developer

MRNA

Moderna, Inc.

Biological Products, (No Diagnostic Substances)•North America•NASDAQ

Related Pipeline

mRNA-4157Phase 3

Melanoma

Fluarix TetraPhase 3

Seasonal Influenza

mRNA-1403Phase 3

Acute Gastroenteritis

Influsplit® TetraPhase 3

Seasonal Influenza

mRNA-1010Phase 3

Seasonal Influenza

View full pipeline

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts